TOPIC

Discovery of novel positive allosteric modulators of the ╬▒7 nicotinic acetylcholine receptor: Scaffold hopping approach

Journal

European Journal of Medicinal Chemistry

Author(s)

Istv├ín Ledneczki, P├íl Tapolcs├ínyi, Eszter G├íbor, Andr├ís Visegr├ídy, M├írton Vass, J├ínos ├ëles, Patrik Holm, Anita Horv├íth, Anik├│ Pocsai, S├índor Mah├│, Istv├ín Greiner, Bal├ízs Kr├ímos, Zolt├ín B├ęni, J├ínos K├│ti, Anna E. K├íncz, M├írta Th├ín, S├índor Kolok, Judit Laszy, Ottilia Bal├ízs, Gyula Bugovits, J├│zsef Nagy, M├│nika Vastag, ├ügota Sz├íjli, ├ëva Boz├│, Gy├Ârgy L├ęvay, Bal├ízs Lendvai, Zsolt N├ęmethy

Year

2021

The paper focuses on the scaffold hopping-based discovery and characterization of novel nicotinic alpha 7 receptor positive modulator (α7 nAChR PAM) ligands around the reference molecule (A-867744). First, substantial efforts were carried out to assess the importance of the various pharmacophoric elements on the in vitro potency (SAR evaluation) by chemical modifications. Subsequently, several new derivatives with versatile, heteroaromatic central cores were synthesized and characterized. A promising, pyrazole-containing new chemotype with good physicochemical and in vitro parameters was identified. Retrospective analysis based on homology modeling was also carried out. Besides its favorable in vitro characteristics, the most advanced derivative 69 also showed in vivo efficacy in a rodent model of cognition (scopolamine-induced amnesia in the mouse place recognition test) and acceptable pharmacokinetic properties. Based on the in vivo data, the resulting molecule with advanced drug-like characteristics has the possibility to improve cognitive performance in a biologically relevant dose range, further strengthening the view of the supportive role of α7 nACh receptors in the cognitive processes.

Go to journal

Get in Touch

We strive to provide the best for our customers, and we are always ready to help. Please let us know if you have a question for us.

Follow us